Connecting Phytochemicals, Epigenetics, and Healthy Aging: Is Metabolism the Missing Link?

Inflammation, Advancing Age and Nutrition: Research and Clinical Interventions

Volumn , Issue , 2013, Pages 111-123

  Szarc vel Szic, Katarzyna ^a   Palagani, Ajay ^a   Chirumamilla, Chandra Sekhar ^a   Diddens, Jolien ^a   Berghe, Wim Vanden ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Aging; Epigenetics; Inflammation; Metabolism; Oxidative stress; Phytochemicals; Xenohormesis

Indexed keywords

EID: 84902398972     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-397803-5.00010-1     Document Type: Chapter

References (192)

1. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., et al. Finding the missing heritability of complex diseases. Nature 2009, 461(7265):747-753.
2. Maher B. Personal genomes: The case of the missing heritability. Nature 2008, 456(7218):18-21.
3. Miller R.L., Ho S.M. Environmental epigenetics and asthma: current concepts and call for studies. Am J Respir Crit Care Med 2008, 177(6):567-573.
4. Villeneuve L.M., Natarajan R. The Role of Epigenetics in the Pathology of Diabetic Complications. Am J Physiol Renal Physiol 2010, 299(1):F14-F25.
5. Guil S., Esteller M. DNA methylomes, histone codes and miRNAs: tying it all together. Int J Biochem Cell Biol 2009, 41(1):87-95.
6. Schwartz D.A. Epigenetics and environmental lung disease. Proc Am Thorac Soc 2010, 7(2):123-125.
7. Gluckman P.D., Hanson M.A., Cooper C., Thornburg K.L. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008, 359(1):61-73.
8. Godfrey K.M., Gluckman P.D., Hanson M.A. Developmental origins of metabolic disease: life course and intergenerational perspectives. Trends Endocrinol Metab 2010, 21(4):199-205.
9. Davalos V., Esteller M. MicroRNAs and cancer epigenetics: a macrorevolution. Curr Opin Oncol 2010, 22(1):35-45.
10. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 2007, 8(4):286-298.
11. Esteller M. Epigenetics in cancer. N Engl J Med 2008, 358(11):1148-1159.
12. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002, 16(1):6-21.
13. Jones P.A., Liang G. Rethinking how DNA methylation patterns are maintained. Nat Rev Genet 2009, 10(11):805-811.
14. Law J.A., Jacobsen S.E. Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nat Rev Genet 2010, 11(3):204-220.
15. Wang L., Chia N.C., Lu X., Ruden D.M. Hypothesis: Environmental regulation of 5-hydroxymethylcytosine by oxidative stress. Epigenetics 2011, 6(7):853-856.
16. Perillo B., Ombra M.N., Bertoni A., Cuozzo C., Sacchetti S., Sasso A., et al. DNA Oxidation as Triggered by H3K9me2 Demethylation Drives Estrogen-Induced Gene Expression. Science 2008, 319(5860):202-206.
17. Chouliaras L., van den Hove D.L., Kenis G., Keitel S., Hof P.R., van Os J., et al. Age-related increase in levels of 5-hydroxymethylcytosine in mouse hippocampus is prevented by caloric restriction. Curr Alzheimer Res 2012, 9(5):536-544.
18. Li Y., Daniel M., Tollefsbol T.O. Epigenetic regulation of caloric restriction in aging. BMC Medicine 2011, 9(1):98.
19. Illi B., Colussi C., Grasselli A., Farsetti A., Capogrossi M.C., Gaetano C. NO sparks off chromatin: tales of a multifaceted epigenetic regulator. Pharmacol Ther 2009, 123(3):344-352.
20. Chi P., Allis C.D., Wang G.G. Covalent histone modifications-miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer 2010, 10(7):457-469.
21. Ernst J., Kellis M. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat Biotechnol 2010, 28(8):817-825.
22. Ernst J., Kheradpour P., Mikkelsen T.S., Shoresh N., Ward L.D., Epstein C.B., et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011, 473(7345):43-49.
23. Luo J., Kuo M.H. Linking nutrient metabolism to epigenetics. Cell Science Reviews 2009, 6:49-54.
24. Bellet M.M., Sassone-Corsi P. Mammalian circadian clock and metabolism-the epigenetic link. J Cell Sci 2010, 123(Pt 22):3837-3848.
25. Chang J., Zhang B., Heath H., Galjart N., Wang X., Milbrandt J. Nicotinamide adenine dinucleotide (NAD)-regulated DNA methylation alters CCCTC-binding factor (CTCF)/cohesin binding and transcription at the BDNF locus. Proc Natl Acad Sci U S A 2010, 107(50):21836-21841.
26. Wallace D.C. Bioenergetics and the epigenome: interface between the environment and genes in common diseases. Dev Disabil Res Rev 2010, 16(2):114-119.
27. Wallace D.C. The epigenome and the mitochondrion: bioenergetics and the environment [corrected]. Genes Dev 2010, 24(15):1571-1573.
28. Ladurner A.G. Chromatin places metabolism center stage. Cell 2009, 138(1):18-20.
29. Simpson N.E., Tryndyak V.P., Pogribna M., Beland F.A., Pogribny I.P. Modifying metabolically sensitive histone marks by inhibiting glutamine metabolism affects gene expression and alters cancer cell phenotype. Epigenetics 2012, 7(12). 1413-2.
30. Zhu J., Adli M., Zou J.Y., Verstappen G., Coyne M., Zhang X., et al. Genome-wide Chromatin State Transitions Associated with Developmental and Environmental Cues. Cell 2013, 152(3):642-654.
31. Dunham I., Kundaje A., Aldred S.F., Collins P.J., Davis C.A., Doyle F., et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489(7414):57-74.
32. Moving AHEAD with an international human epigenome project. Nature 2008, 454(7205):711-715.
33. Altucci L., Stunnenberg H.G. Time for epigenetics. Int J Biochem Cell Biol 2009, 41(1):2-3.
34. Liu Y., Aryee M.J., Padyukov L., Fallin M.D., Hesselberg E., Runarsson A., et al. Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. Nat Biotechnol 2013, 31(2):142-147.
35. Christensen B.C., Houseman E.A., Marsit C.J., Zheng S., Wrensch M.R., Wiemels J.L., et al. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet 2009, 5(8):e1000602.
36. Langevin S.M., Houseman E.A., Christensen B.C., Wiencke J.K., Nelson H.H., Karagas M.R., et al. The influence of aging, environmental exposures and local sequence features on the variation of DNA methylation in blood. Epigenetics 2011, 6(7):908-919.
37. Tan Q., Christiansen L., Thomassen M., Kruse T.A., Christensen K. Twins for epigenetic studies of human aging and development. Ageing Res Rev 2013, 12(1):182-187.
38. Toperoff G., Aran D., Kark J.D., Rosenberg M., Dubnikov T., Nissan B., et al. Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum Mol Genet 2012, 21(2):371-383.
39. Zhao J., Forsberg C.W., Goldberg J., Smith N.L., Vaccarino V. MAOA promoter methylation and susceptibility to carotid atherosclerosis: role of familial factors in a monozygotic twin sample. BMC Med Genet 2012, 13:100.
40. Teperino R., Schoonjans K., Auwerx J. Histone methyl transferases and demethylases; can they link metabolism and transcription?. Cell Metab 2010, 12(4):321-327.
41. Bonuccelli G., Tsirigos A., Whitaker-Menezes D., Pavlides S., Pestell R.G., Chiavarina B., et al. Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 2010, 9(17):3506-3514.
42. Martinez-Outschoorn U.E., Prisco M., Ertel A., Tsirigos A., Lin Z., Pavlides S., et al. Ketones and lactate increase cancer cell "stemness," driving recurrence, metastasis and poor clinical outcome in breast cancer: Achieving personalized medicine via Metabolo-Genomics. Cell Cycle 2011, 10(8):1271-1286.
43. Figueroa M.E., Abdel-Wahab O., Lu C., Ward P.S., Patel J., Shih A., et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 2010, 18(6):553-567.
44. Wellen K.E., Hatzivassiliou G., Sachdeva U.M., Bui T.V., Cross J.R., Thompson C.B. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 2009, 324(5930):1076-1080.
45. Rathmell J.C., Newgard C.B. Biochemistry. A glucose-to-gene link. Science 2009, 324(5930):1021-1022.
46. Katada S., Imhof A., Sassone-Corsi P. Connecting Threads: Epigenetics and Metabolism. Cell 2012, 148(1-2):24-28.
47. Feng D., Lazar Mitchell A. Clocks, Metabolism, and the Epigenome. Mol Cell 2012, 47(2):158-167.
48. Kirchner H., Osler M.E., Krook A., Zierath J.R. Epigenetic flexibility in metabolic regulation: disease cause and prevention?. Trends Cell Biol 2012, pii: S0962-8924(12)00222-X. http://dx.doi.org.10.1016/j.tcb.2012.11.008. [Epub ahead of print].
49. Arrowsmith C.H., Bountra C., Fish P.V., Lee K., Schapira M. Epigenetic protein families: a new frontier for drug discovery. Nat Rev Drug Discov 2012, 11(5):384-400.
50. Shirodkar A.V., Marsden P.A. Epigenetics in cardiovascular disease. Curr Opin Cardiol 2011, 26(3):209-215.
51. Ordovas J.M., Smith C.E. Epigenetics and cardiovascular disease. Nat Rev Cardiol 2010, 7(9):510-519.
52. Wang X., Jin H. The epigenetic basis of the Warburg effect. Epigenetics 2010, 5(7):566-568.
53. Liu X., Wang X., Zhang J., Lam E.K., Shin V.Y., Cheng A.S., et al. Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis. Oncogene 2010, 29(3):442-450.
54. McCarthy N. Metabolism: unmasking an oncometabolite. Nat Rev Cancer 2012, 12(4):229.
55. Chowdhury R., Yeoh K.K., Tian Y.M., Hillringhaus L., Bagg E.A., Rose N.R., et al. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep 2011, 12(5):463-469.
56. Joven J., Rull A., Rodriguez-Gallego E., Camps J., Riera-Borrull M., Hernández-Aguilera A., et al. Multifunctional targets of dietary polyphenols in disease: A case for the chemokine network and energy metabolism. Food Chem Toxicol 2013, 51:267-279.
57. Huang J., Plass C., Gerhauser C. Cancer chemoprevention by targeting the epigenome. Curr Drug Targets 2011, 12(13):1925-1956.
58. Vel Szic K.S., Ndlovu M.N., Haegeman G., Vanden Berghe W. Nature or nurture: let food be your epigenetic medicine in chronic inflammatory disorders. Biochem Pharmacol 2010, 80(12):1816-1832.
59. Cooney C.A. Germ cells carry the epigenetic benefits of grandmother's diet. Proc Natl Acad Sci U S A 2006, 103(46):17071-17072.
60. Weaver I.C. Shaping adult phenotypes through early life environments. Birth Defects Res Part C Embryo Today 2009, 87(4):314-326.
61. Burdge G.C., Lillycrop K.A. Nutrition, Epigenetics, and Developmental Plasticity: Implications for Understanding Human Diseas. Annu Rev Nutr 2010, 30:315-339.
62. Aguilera O., Fernandez A.F., Munoz A., Fraga M.F. Epigenetics and environment: a complex relationship. J Appl Physiol 2010, 109(1):243-251.
63. Youngson N.A., Whitelaw E. Transgenerational epigenetic effects. Annu Rev Genomics Hum Genet 2008, 9:233-257.
64. Gallou-Kabani C., Vige A., Gross M.S., Junien C. Nutri-epigenomics: lifelong remodelling of our epigenomes by nutritional and metabolic factors and beyond. Clin Chem Lab Med 2007, 45(3):321-327.
65. Anway M.D., Cupp A.S., Uzumcu M., Skinner M.K. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 2005, 308(5727):1466-1469.
66. Anway M.D., Skinner M.K. Epigenetic transgenerational actions of endocrine disruptors. Endocrinology 2006, 147(6 Suppl):S43-S49.
67. Jirtle R.L., Skinner M.K. Environmental epigenomics and disease susceptibility. Nat Rev Genet 2007, 8(4):253-262.
68. Barker D.J., Martyn C.N. The maternal and fetal origins of cardiovascular disease. J Epidemiol Community Health 1992, 46(1):8-11.
69. Jackson A.A., Burdge G.C., Lillycrop K.A. Diet, nutrition and modulation of genomic expression in fetal origins of adult disease. World Rev Nutr Diet 2010, 101:56-72.
70. Chmurzynska A. Fetal programming: link between early nutrition, DNA methylation, and complex diseases. Nutr Rev 2010, 68(2):87-98.
71. Kaminsky Z.A., Tang T., Wang S.C., Ptak C., Oh G.H., Wong A.H., et al. DNA methylation profiles in monozygotic and dizygotic twins. Nat Genet 2009, 41(2):240-245.
72. Petronis A. Epigenetics and twins: three variations on the theme. Trends Genet 2006, 22(7):347-350.
73. Dolinoy D.C., Weidman J.R., Waterland R.A., Jirtle R.L. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 2006, 114(4):567-572.
74. Dolinoy D.C., Jirtle R.L. Environmental epigenomics in human health and disease. Environ Mol Mutagen 2008, 49(1):4-8.
75. Waterland R.A. Is epigenetics an important link between early life events and adult disease?. Horm Res 2009, 71(Suppl. 1):13-16.
76. Vandegehuchte M.B., Lemiere F., Vanhaecke L., Vanden Berghe W., Janssen C.R. Direct and transgenerational impact on Daphnia magna of chemicals with a known effect on DNA methylation. Comparative Biochemistry and Physiology Toxicology and Pharmacology 2010, 151(3):278-285.
77. Gabor Miklos G.L., Maleszka R. Epigenomic communication systems in humans and honey bees: From molecules to behavior. Horm Behav 2010, 59(3):399-406.
78. Kucharski R., Maleszka J., Foret S., Maleszka R. Nutritional control of reproductive status in honeybees via DNA methylation. Science 2008, 319(5871):1827-1830.
79. Maleszka R. Epigenetic integration of environmental and genomic signals in honey bees: the critical interplay of nutritional, brain and reproductive networks. Epigenetics 2008, 3(4):188-192.
80. Foret S., Kucharski R., Pittelkow Y., Lockett G.A., Maleszka R. Epigenetic regulation of the honey bee transcriptome: unravelling the nature of methylated genes. BMC Genomics 2009, 10:472.
81. Foret S., Kucharski R., Pellegrini M., Feng S., Jacobsen S.E., Robinson G.E., et al. DNA methylation dynamics, metabolic fluxes, gene splicing, and alternative phenotypes in honey bees. Proc Natl Acad Sci U S A 2012, 109(13):4968-4973.
82. Kamakura M. Royalactin induces queen differentiation in honeybees. Nature 2011, 473(7348):478-483.
83. Münch D., Amdam G.V. The curious case of aging plasticity in honey bees. FEBS Letters 2010, 584(12):2496-2503.
84. Li X., Huang C., Xue Y. Contribution of Lipids in Honeybee (Apis mellifera) Royal Jelly to Health. J Med Food 2013, 16(2):96-102.
85. Painter R.C., Osmond C., Gluckman P., Hanson M., Phillips D.I., Roseboom T.J. Transgenerational effects of prenatal exposure to the Dutch famine on neonatal adiposity and health in later life. BJOG 2008, 115(10):1243-1249.
86. Lumey L.H., Stein A.D. Transgenerational effects of prenatal exposure to the Dutch famine. BJOG 2009, 116(6):868. author reply.
87. Roseboom T., de Rooij S., Painter R. The Dutch famine and its long-term consequences for adult health. Early Hum Dev 2006, 82(8):485-491.
88. Whitelaw E. Epigenetics: sins of the fathers, and their fathers. Eur J Hum Genet 2006, 14(2):131-132.
89. Kaati G., Bygren L.O., Edvinsson S. Cardiovascular and diabetes mortality determined by nutrition during parents' and grandparents' slow growth period. Eur J Hum Genet 2002, 10(11):682-688.
90. Hanson M.A., Gluckman P.D. Developmental processes and the induction of cardiovascular function: conceptual aspects. J Physiol 2005, 565(Pt 1):27-34.
91. Pons D., de Vries F.R., van den Elsen P.J., Heijmans B.T., Quax P.H., Jukema J.W. Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease. European Heart Journal 2009, 30(3):266-277.
92. Kim M, Long TI, Arakawa K, Wang R, Yu MC, Laird PW. DNA methylation as a biomarker for cardiovascular disease risk. PLoS One. 5(3): e9692.
93. Waldo S.W., Li Y., Buono C., Zhao B., Billings E.M., Chang J., et al. Heterogeneity of human macrophages in culture and in atherosclerotic plaques. Am J Pathol 2008, 172(4):1112-1126.
94. Lund G., Zaina S. Atherosclerosis risk factors can impose aberrant DNA methylation patterns: a tale of traffic and homocysteine. Curr Opin Lipidol 2009, 20(5):448-449.
95. Lund G., Zaina S. Epigenetics, transgenerational effects and risk factors for atherosclerosis. Curr Opin Lipidol 2009, 20(2):150-151.
96. Wierda R.J., Geutskens S.B., Jukema J.W., Quax P.H., van den Elsen P.J. Epigenetics in atherosclerosis and inflammation. J Cell Mol Med 2010, 14(6A). 1225-4.
97. Sharma P., Senthilkumar R.D., Brahmachari V., Sundaramoorthy E., Mahajan A., Sharma A., et al. Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies. Lipids Health Dis 2006, 5:1.
98. Chen N.C., Yang F., Capecci L.M., Gu Z., Schafer A.I., Durante W., et al. Regulation of homocysteine metabolism and methylation in human and mouse tissues. FASEB J 2010, 24(8):2804-2817.
99. Jiang Y., Sun T., Xiong J., Cao J., Li G., Wang S. Hyperhomocysteinemia-mediated DNA hypomethylation and its potential epigenetic role in rats. Acta Biochim Biophys Sin (Shanghai) 2007, 39(9):657-667.
100. Kim J.M., Hong K., Lee J.H., Lee S., Chang N. Effect of folate deficiency on placental DNA methylation in hyperhomocysteinemic rats. J Nutr Biochem 2009, 20(3):172-176.
101. Bistulfi G., Vandette E., Matsui S., Smiraglia D.J. Mild folate deficiency induces genetic and epigenetic instability and phenotype changes in prostate cancer cells. BMCBiol 2010, 8:6.
102. Ghoshal K., Li X., Datta J., Bai S., Pogribny I., Pogribny M., et al. A folate- and methyl-deficient diet alters the expression of DNA methyltransferases and methyl CpG binding proteins involved in epigenetic gene silencing in livers of F344 rats. J Nutr 2006, 136(6):1522-1527.
103. Ulrich C.M., Reed M.C., Nijhout H.F. Modeling folate, one-carbon metabolism, and DNA methylation. Nutr Rev 2008, 66(Suppl. 1):S27-S30.
104. Pogribny I.P., Tryndyak V.P., Muskhelishvili L., Rusyn I., Ross S.A. Methyl deficiency, alterations in global histone modifications, and carcinogenesis. J Nutr 2007, 137(1 Suppl):216S-222S.
105. Manach C., Mazur A., Scalbert A. Polyphenols and prevention of cardiovascular diseases. Curr Opin Lipidol 2005, 16(1):77-84.
106. Fisher N.D., Hollenberg N.K. Aging and vascular responses to flavanol-rich cocoa. J Hypertens 2006, 24(8):1575-1580.
107. Sies H., Schewe T., Heiss C., Kelm M. Cocoa polyphenols and inflammatory mediators. Am J Clin Nutr 2005, 81(1 Suppl):304S-312S.
108. Heiss C., Kleinbongard P., Dejam A., Perre S., Schroeter H., Sies H., et al. Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. J Am Coll Cardiol 2005, 46(7):1276-1283.
109. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: the invivo evidence. Nat Rev Drug Discov 2006, 5(6):493-506.
110. Bertelli A.A., Das D.K. Grapes, wines, resveratrol, and heart health. J Cardiovasc Pharmacol 2009, 54(6):468-476.
111. Turunen M.P., Aavik E., Yla-Herttuala S. Epigenetics and atherosclerosis. Biochimica et biophysica acta 2009, 1790(9):886-891.
112. van Straten E.M., Bloks V.W., Huijkman N.C., Baller J.F., Meer H., Lutjohann D., et al. The liver X-receptor gene promoter is hypermethylated in a mouse model of prenatal protein restriction. Am J Physiol Regul Integr Comp Physiol 2010, 298(2):R275-R282.
113. Burdge G.C., Slater-Jefferies J., Torrens C., Phillips E.S., Hanson M.A., Lillycrop K.A. Dietary protein restriction of pregnant rats in the F0 generation induces altered methylation of hepatic gene promoters in the adult male offspring in the F1 and F2 generations. Br J Nutr 2007, 97(3):435-439.
114. Lillycrop K.A., Phillips E.S., Jackson A.A., Hanson M.A., Burdge G.C. Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J Nutr 2005, 135(6):1382-1386.
115. De Santa F., Totaro M.G., Prosperini E., Notarbartolo S., Testa G., Natoli G. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 2007, 130(6):1083-1094.
116. Tateishi K., Okada Y., Kallin E.M., Zhang Y. Role of Jhdm2a in regulating metabolic gene expression and obesity resistance. Nature 2009, 458(7239):757-761.
117. Reddy M.A., Villeneuve L.M., Wang M., Lanting L., Natarajan R. Role of the lysine-specific demethylase 1 in the proinflammatory phenotype of vascular smooth muscle cells of diabetic mice. Circ Res 2008, 103(6):615-623.
118. Brasacchio D., Okabe J., Tikellis C., Balcerczyk A., George P., Baker E.K., et al. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 2009, 58(5):1229-1236.
119. El-Osta A., Brasacchio D., Yao D., Pocai A., Jones P.L., Roeder R.G., et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 2008, 205(10):2409-2417.
120. Attig L., Gabory A., Junien C. Nutritional developmental epigenomics: immediate and long-lasting effects. Proc Nutr Soc 2010, 69(2):221-231.
121. Gallou-Kabani C., Junien C. Nutritional epigenomics of metabolic syndrome: new perspective against the epidemic. Diabetes 2005, 54(7):1899-1906.
122. Karemaker R., Karemaker J.M., Kavelaars A., Tersteeg-Kamperman M., Baerts W., Veen S., et al. Effects of neonatal dexamethasone treatment on the cardiovascular stress response of children at school age. Pediatrics 2008, 122(5):978-987.
123. Barres R., Osler M.E., Yan J., Rune A., Fritz T., Caidahl K., et al. Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metabolism 2009, 10(3):189-198.
124. Plagemann A., Roepke K., Harder T., Brunn M., Harder A., Wittrock-Staar M., et al. Epigenetic malprogramming of the insulin receptor promoter due to developmental overfeeding. J Perinat Med 2010, 38(4):393-400.
125. Plagemann A., Harder T., Brunn M., Harder A., Roepke K., Wittrock-Staar M., et al. Hypothalamic proopiomelanocortin promoter methylation becomes altered by early overfeeding: an epigenetic model of obesity and the metabolic syndrome. J Physiol 2009, 587(Pt 20):4963-4976.
126. Burdge G.C., Lillycrop K.A., Jackson A.A. Nutrition in early life, and risk of cancer and metabolic disease: alternative endings in an epigenetic tale?. Br J Nutr 2009, 101(5):619-630.
127. De Assis S., Hilakivi-Clarke L. Timing of dietary estrogenic exposures and breast cancer risk. Ann N Y Acad Sci 2006, 1089:14-35.
128. Guerrero-Bosagna C.M., Sabat P., Valdovinos F.S., Valladares L.E., Clark S.J. Epigenetic and phenotypic changes result from a continuous pre and post natal dietary exposure to phytoestrogens in an experimental population of mice. BMC Physiol 2008, 8:17.
129. Hunter P. We are what we eat. The link between diet, evolution and non-genetic inheritance. EMBO Rep 2008, 9(5):413-415.
130. Fraga M.F., Ballestar E., Paz M.F., Ropero S., Setien F., Ballestar M.L., et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 2005, 102(30):10604-10609.
131. Waterland R.A., Travisano M., Tahiliani K.G., Rached M.T., Mirza S. Methyl donor supplementation prevents transgenerational amplification of obesity. Int J Obes (Lond) 2008, 32(9):1373-1379.
132. Waterland R.A., Jirtle R.L. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 2004, 20(1):63-68.
133. Kirk H., Cefalu W.T., Ribnicky D., Liu Z., Eilertsen K.J. Botanicals as epigenetic modulators for mechanisms contributing to development of metabolic syndrome. Metabolism 2008, 57(7 Suppl. 1):S16-S23.
134. Surani M.A., Ancelin K., Hajkova P., Lange U.C., Payer B., Western P., et al. Mechanism of mouse germ cell specification: a genetic program regulating epigenetic reprogramming. Cold Spring Harb Symp Quant Biol 2004, 69:1-9.
135. Hajkova P., Ancelin K., Waldmann T., Lacoste N., Lange U.C., Cesari F., et al. Chromatin dynamics during epigenetic reprogramming in the mouse germ line. Nature 2008, 452(7189):877-881.
136. Wossidlo M., Nakamura T., Lepikhov K., Marques C.J., Zakhartchenko V., Boiani M., et al. 5-Hydroxymethylcytosine in the mammalian zygote is linked with epigenetic reprogramming. Nat Commun 2011, 2:241.
137. Chong S., Youngson N.A., Whitelaw E. Heritable germline epimutation is not the same as transgenerational epigenetic inheritance. Nat Genet 2007, 39(5):574-575. author reply 5-6.
138. Blewitt M.E., Vickaryous N.K., Paldi A., Koseki H., Whitelaw E. Dynamic Reprogramming of DNA Methylation at an Epigenetically Sensitive Allele in Mice. PLoS Genet 2006, 2(4):e49.
139. Bracken A.P., Helin K. Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Cancer 2009, 9(11):773-784.
140. Li Y., Kong D., Wang Z., Sarkar F.H. Regulation of microRNAs by Natural Agents: An Emerging Field in Chemoprevention and Chemotherapy Research. Pharm Res 2010, 27(6):1027-1041.
141. Ruden D.M., Xiao L., Garfinkel M.D., Lu X. Hsp90 and environmental impacts on epigenetic states: a model for the trans-generational effects of diethylstibesterol on uterine development and cancer. Hum Mol Genet 2005, 14(Spec No 1):R149-R155.
142. Sollars V., Lu X., Xiao L., Wang X., Garfinkel M.D., Ruden D.M. Evidence for an epigenetic mechanism by which Hsp90 acts as a capacitor for morphological evolution. Nat Genet 2003, 33(1):70-74.
143. Ruden D.M., De Luca M., Garfinkel M.D., Bynum K.L., Lu X. Drosophila nutrigenomics can provide clues to human gene-nutrient interactions. Annu Rev Nutr 2005, 25:499-522.
144. Dijsselbloem N., Vanden Berghe W., De Naeyer A., Haegeman G. Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections: multi-purpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapy. Biochem Pharmacol 2004, 68:1171-1185.
145. Surh Y.J. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003, 3(10):768-780.
146. Blanpain C., Fuchs E. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol 2009, 10(3):207-217.
147. Crea F., Mathews L.A., Farrar W.L., Hurt E.M. Targeting prostate cancer stem cells. Anticancer Agents Med Chem 2009, 9(10):1105-1113.
148. Kawasaki B.T., Hurt E.M., Mistree T., Farrar W.L. Targeting cancer stem cells with phytochemicals. Mol Interv 2008, 8(4):174-184.
149. Shytle R.D., Ehrhart J., Tan J., Vila J., Cole M., Sanberg C.D., et al. Oxidative stress of neural, hematopoietic, and stem cells: protection by natural compounds. Rejuvenation Res 2007, 10(2):173-178.
150. Bickford P.C., Tan J., Shytle R.D., Sanberg C.D., El-Badri N., Sanberg P.R. Nutraceuticals synergistically promote proliferation of human stem cells. Stem Cells Dev 2006, 15(1):118-123.
151. Zhou J., Zhang H., Gu P., Bai J., Margolick J.B., Zhang Y. NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells. Breast Cancer Res Treat 2008, 111(3):419-427.
152. Grivennikov S.I., Karin M. Inflammation and oncogenesis: a vicious connection. Curr Opin Genet Dev 2010, 20(1):65-71.
153. Aggarwal B.B. Inflammation, a silent killer in cancer is not so silent!. Curr Opin Pharmacol 2009, 9(4):347-350.
154. Aggarwal B.B., Gehlot P. Inflammation and cancer: how friendly is the relationship for cancer patients?. Curr Opin Pharmacol 2009, 9(4):351-369.
155. Anand P., Kunnumakkara A.B., Sundaram C., Harikumar K.B., Tharakan S.T., Lai O.S., et al. Cancer is a preventable disease that requires major lifestyle changes. PharmRes 2008, 25(9):2097-2116.
156. Arasaradnam R.P., Commane D.M., Bradburn D., Mathers J.C. A review of dietary factors and its influence on DNA methylation in colorectal carcinogenesis. Epigenetics 2008, 3(4):193-198.
157. Delage B., Dashwood R.H. Dietary manipulation of histone structure and function. Annu Rev Nutr 2008, 28:347-366.
158. Link A., Balaguer F., Goel A. Cancer chemoprevention by dietary polyphenols: Promising role for epigenetics. Biochem Pharmacol 2010, 80(12):1771-1792.
159. Folmer F., Orlikova B., Schnekenburger M., Dicato M., Diederich M. Naturally occurring regulators of histone acetylation/deacetylation. Current Nutrition & Food Science 2010, 6:78-99.
160. Hauser A.T., Jung M. Targeting epigenetic mechanisms: potential of natural products in cancer chemoprevention. Planta Medica 2008, 74(13):1593-1601.
161. Kontogiorgis C., Bompou E., Ntella M., Vanden Berghe W. Natural Products from Mediterranean Diet: From Anti-Inflammatory Agents to Dietary Epigenetic Modulators. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2010, 6:101-124.
162. Fang M., Chen D., Yang C.S. Dietary polyphenols may affect DNA methylation. J Nutr 2007, 137(1 Suppl):223S-228S.
163. Suzuki T., Miyata N. Epigenetic control using natural products and synthetic molecules. Curr Med Chem 2006, 13(8):935-958.
164. Vaquero A., Reinberg D. Calorie restriction and the exercise of chromatin. Genes Dev 2009, 23(16):1849-1869.
165. Vanden Berghe W. Epigenetic impact of dietary polyphenols in cancer chemoprevention: lifelong remodeling of our epigenomes. Pharmacol Res 2012, 65(6):565-576.
166. Szarc vel Szic K., Ndlovu M.N., Haegeman G., Vanden Berghe W. Nature or nurture: let food be your epigenetic medicine in chronic inflammatory disorders. Biochem Pharmacol 2010, 80(12):1816-1832.
167. Vanden Berghe W., Sabbe L., Kaileh M., Haegeman G., Heyninck K. Molecular insight in the multifunctional activities of Withaferin A. Biochem Pharmacol 2012, 84(10):1282-1291.
168. Ndlovu M.N., Van Lint C., Van Wesemael K., Callebert P., Chalbos D., Haegeman G., et al. Hyperactivated NF-{kappa}B and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the interleukin-6 gene promoter in metastatic breast cancer cells. Mol Cell Biol 2009, 29(20):5488-5504.
169. Mai A., Cheng D., Bedford M.T., Valente S., Nebbioso A., Perrone A., et al. Epigenetic multiple ligands: mixed histone/protein methyltransferase, acetyltransferase, and class III deacetylase (sirtuin) inhibitors. J Med Chem 2008, 51(7):2279-2290.
170. Kuniyasu H. The Roles of Dietary PPARgamma Ligands for Metastasis in Colorectal Cancer. PPAR research 2008, 2008:529720.
171. Denison M.S., Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 2003, 43:309-334.
172. Darbre P.D., Charles A.K. Environmental oestrogens and breast cancer: evidence for combined involvement of dietary, household and cosmetic xenoestrogens. Anticancer Res 2010, 30(3):815-827.
173. Newbold R.R., Padilla-Banks E., Jefferson W.N. Environmental estrogens and obesity. Mol Cell Endocrinol 2009, 304(1-2):84-89.
174. Manach C., Donovan J.L. Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radic Res 2004, 38(8):771-785.
175. Manach C., Williamson G., Morand C., Scalbert A., Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005, 81(1 Suppl):230S-242S.
176. Manach C., Scalbert A., Morand C., Remesy C., Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004, 79(5):727-747.
177. Williamson G., Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 2005, 81(1 Suppl):243S-255S.
178. El-Osta A. Redox Mediating Epigenetic Changes Confer Metabolic Memories. Circ Res 2012, 111(3):262-264.
179. Zheng Y.G., Wu J., Chen Z., Goodman M. Chemical regulation of epigenetic modifications: opportunities for new cancer therapy. Med Res Rev 2008, 28(5):645-687.
180. Seet B.T., Dikic I., Zhou M.M., Pawson T. Reading protein modifications with interaction domains. Nat Rev Mol Cell Biol 2006, 7(7):473-483.
181. Wigle TJ, Herold JM, Senisterra GA, Vedadi M, Kireev DB, Arrowsmith CH, et al. Screening for inhibitors of low-affinity epigenetic peptide-protein interactions: an AlphaScreen-based assay for antagonists of methyl-lysine binding proteins. J Biomol Screen. 15(1): 62-71.
182. Imai S., Guarente L. Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases. Trends Pharmacol Sci 2010, 31(5):212-220.
183. Chiang E.P., Wang Y.C., Chen W.W., Tang F.Y. Effects of insulin and glucose on cellular metabolic fluxes in homocysteine transsulfuration, remethylation, S-adenosylmethionine synthesis, and global deoxyribonucleic acid methylation. J Clin Endocrinol Metab 2009, 94(3):1017-1025.
184. Lee D.H., Jacobs D.R., Porta M. Hypothesis: a unifying mechanism for nutrition and chemicals as lifelong modulators of DNA hypomethylation. Environ Health Perspect 2009, 117(12):1799-1802.
185. Whittle J.R., Powell M.J., Popov V.M., Shirley L.A., Wang C., Pestell R.G. Sirtuins, nuclear hormone receptor acetylation and transcriptional regulation. Trends Endocrinol Metab 2007, 18(9):356-364.
186. Howitz K.T., Sinclair D.A. Xenohormesis: Sensing the Chemical Cues of Other Species. Cell 2008, 133(3):387-391.
187. Paul A.T., Gohil V.M., Bhutani K.K. Modulating TNF-alpha signaling with natural products. Drug Discov Today 2006, 11(15-16):725-732.
188. Rios J.L., Recio M.C., Escandell J.M., Andujar I. Inhibition of transcription factors by plant-derived compounds and their implications in inflammation and cancer. Curr Pharm Des 2009, 15(11):1212-1237.
189. Deorukhkar A., Krishnan S., Sethi G., Aggarwal B.B. Back to basics: how natural products can provide the basis for new therapeutics. Expert Opin Investig Drugs 2007, 16(11):1753-1773.
190. Khanna D., Sethi G., Ahn K.S., Pandey M.K., Kunnumakkara A.B., Sung B., et al. Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol 2007, 7(3):344-351.
191. Bremner P., Heinrich M. Natural products as targeted modulators of the nuclear factor-kappaB pathway. J Pharm Pharmacol 2002, 54(4):453-472.
192. Karin M., Yamamoto Y., Wang Q.M. The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov 2004, 3(1):17-26.